Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.390
-0.030 (-2.11%)
At close: Nov 20, 2024, 4:00 PM
1.430
+0.040 (2.88%)
After-hours: Nov 20, 2024, 5:41 PM EST
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $43.36 million as of November 21, 2024. Its market cap has decreased by -65.23% in one year.
Market Cap
43.36M
Enterprise Value
-33.59M
1-Year Change
-65.23%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $43.36M, an increase of 159.65%. That is a compound annual growth rate of 8.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 44.30M | -68.20% |
Dec 29, 2023 | 139.30M | -48.67% |
Dec 30, 2022 | 271.40M | 104.98% |
Dec 31, 2021 | 132.40M | 24.91% |
Dec 31, 2020 | 106.00M | 195.26% |
Dec 31, 2019 | 35.90M | -19.87% |
Dec 31, 2018 | 44.80M | -15.63% |
Dec 29, 2017 | 53.10M | 8.81% |
Dec 30, 2016 | 48.80M | -64.04% |
Dec 31, 2015 | 135.70M | -23.20% |
Dec 31, 2014 | 176.70M | 26.85% |
Dec 31, 2013 | 139.30M | 734.13% |
Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rapid Micro Biosystems | 45.49M |
Calidi Biotherapeutics | 45.39M |
CareCloud | 45.31M |
Serina Therapeutics | 44.46M |
SCYNEXIS | 44.39M |
OncoCyte | 44.28M |
Intensity Therapeutics | 43.24M |
Gain Therapeutics | 43.15M |